Dipyridamole, Valsartan, and Methylprednisolone with Huangkui Capsules

Patients in both groups received 30 mg of dipyridamole tablets (National Drug Administration: H20066585) thrice daily, 90 mg of valsartan capsules (National Drug Administration: H20010811) daily, and 45 mg of methylprednisolone tablets (National Drug Administration: H2220245) daily as an initial dose and 8 mg daily as a maintenance dose. All the above-given drugs were administered orally, and the duration of treatment was 10 weeks.
Patients in the experimental group additionally received 2 g of Huangkui capsules (National Drug Administration: Z19990040) thrice daily. The duration of treatment was 10 weeks.

Free full text: Click here

Yuan L., Cai K, & Zou Y. (2023). Clinical Efficacy of Huangkui Capsule Plus Methylprednisolone for Immunoglobulin A Nephropathy and Its Effect on Renal Function and Serum Inflammatory Factors. Evidence-based Complementary and Alternative Medicine : eCAM, 2023, 3020033.

Publication 2023

Capsules Dipyridamole Drugs Huangkui Methylprednisolone Patients Valsartan

Corresponding Organization :

Other organizations : Yantaishan Hospital

Top 5 similar protocols

Variable analysis

independent variables

Administration of Huangkui capsules (2 g thrice daily) in the experimental group

dependent variables

Clinical outcomes (not explicitly mentioned)

control variables

Dipyridamole tablets (30 mg thrice daily)
Valsartan capsules (90 mg daily)
Methylprednisolone tablets (45 mg daily as initial dose, 8 mg daily as maintenance dose)
Duration of treatment (10 weeks)

controls

Patients in both the experimental and control groups received the same baseline treatments (dipyridamole, valsartan, and methylprednisolone)

Annotations

Based on most similar protocols

Etiam vel ipsum. Morbi facilisis vestibulum nisl. Praesent cursus laoreet felis. Integer adipiscing pretium orci. Nulla facilisi. Quisque posuere bibendum purus. Nulla quam mauris, cursus eget, convallis ac, molestie non, enim. Aliquam congue. Quisque sagittis nonummy sapien. Proin molestie sem vitae urna. Maecenas lorem.

As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!